HSIC vs OMER · P/E 24, rev $12.67B vs $174.0M cap
Henry Schein Inc (HSIC) versus Omeros Corporation (OMER) — a side-by-side from cached financials, not a winner call.
Henry Schein Inc (HSIC) is a medical distribution company listed on NASDAQ.
Omeros Corporation (OMER) is a biotechnology company listed on US.
Latest reported HSIC revenue for 2024-12-28 was $12.67B. Net income was $398.0M. Revenue was up 2.7% from 2023-12-30 to 2024-12-28. HSIC currently screens at market cap $9.11B and trailing P/E 24.2.
OMER does not have a complete income-statement cache yet.
HSIC currently screens at market cap $9.11B and trailing P/E 24.2. OMER currently screens at market cap $174.0M.
Not investment advice. Open the HSIC and OMER stock pages for the full models.
Not investment advice.